Abstract:Objective:This study was designed to evaluate the efficacy and safety of the LEFTEAR closure system for left atrial appendage closure (LAAC) in patients with non-valvular atrial fibrillation (AF) who had contraindications of long-term oral anticoagulation or still high risks of stroke with anticoagulation treatment.Methods:A total of 200 patients with AF underwent LAAC were prospectively recruited in 9 centers nationwide, between April 2014 and March 2019. The enrolled cases had 38-89 (mean 68.3±8.71) years old. There were 112 males (56%) . CHA 2DS 2-VASc scores were (3.5±1.44) points, and HAS-BLED scores (2.5±1.18) points. LAAC was conducted with a novel disc-like closure device, LEFTEAR. Successful closure of LAA was defined as there was no or a small amount of residual shunt (PDL≤3 mm) , evaluated by transesophageal echocardiography (TEE) . The composite end-point events (hemorrhagic/ischemic stroke, systemic embolism, cardiogenic/unexplained death) within 12 months after the procedure were the main efficacy indicators. Severe adverse events (SAE) within 12 months were safety indicators. Results:Total 196 were implanted with an occluder, and the remaining 4 were not (1 case found with an large LAA which the ostium was great than 35 mm above the upper limit of the clinical program, 1 case gave up after failed attempt of LAAC procedure, 2 cases showed "pericardial tamponade" after AF ablation and no attempt was made to continue LAAC) . Among them, the "hybrid procedures" (LAAC+AF ablation) reached up to 133 cases (66.5%) . Up to December 31, 2019, the mean follow-up was 6 (4, 11) months. There were none major composite endpoint events occurred during the perioperative and follow-up periods. SAE were recorded in 10 cases, of which 7 cases were "pericardial tamponade" , and 3 cases of "occluder detachment or displacement" . All SAE occurred in "hybrid procedures" cases, of which 9 cases occurred in the perioperative period (90%) . Six cases of "pericardial tamponade" were recorded in the perioperative period, and only 2 cases required emergency surgery. The successful rate of immediate LAAC was 100%, among which 178 cases (90.8%, 178/196) had no residual shunt. A total of 153 cases (79.7%, 153/192) had completed at least one follow-up TEE examination, and the successful LAAC rate was 98.7% (151/153 cases) , with no events of device-related thrombosis.Conclusions:LAAC with a novel disc-like occlude, named LEFTEAR, was generally effective and safe. The "hybrid procedures" increased the incidence of adverse events to some extent. This study was the first-in-human study of LEFTEAR, thus further larger sample studies are still needed to verify.

Three-dimensional transesophageal echocardiography evaluation of changes in parameters of mitral value pre- and post-left atrial appendage closure

Clinical Implication of Real-Time Three-Dimensional Transesophageal Echocardiography in Percutaneous Transcatheter Left Atrial Appendage Closure with Amplatzer Cardiac Plug(ACP) Device for Non-Valvular Atrial Fibrillation Patients

Assessment of Left Atrial Appendage Volume and Function Using Real-Time Three-Dimensional Transesophageal Echocardiography in Patients with Nonvalvular Atrial Fibrillation

Assessment of Left Atrial Strain in Patients Pre-and Post-Mitral Valvuloplasty by Using Two-Dimensional Speckle Tracking Echocardiography

Assessment of Left Atrial Appendage Morphology and Function in Patients with Non-valvular Paroxysmal Atrial Fibrillation with Different Rhythms Using Real-Time 3D Transesophageal Echocardiography.

Utility of Real-Time Three-Dimensional Transesophageal Echocardiography in the Intraoperative Assessment of Mltral Valve Repair

Quantitative Evaluation of Left and Right Ventricular Function by Serial Measuring Tei Index in Patients with Atrial Septal Defects Before and After Amplatzer Closure

Comparation of three-dimensional transesophageal echocardiography and other imaging techniques in conducting percutaneous left atrial appendage occlusion

Application of Real-Time Three-Dimensional Transesophageal Echocardiography in Percutaneous Left Atrial Appendage Closure and Its Follow-Up

Transthoracic Echocardiographic Value in Transcatheter Closure of Perimembranous Ventricular Septal Defect Using Amplatzer Occluder

3D Transesophageal Echocardiography in the Selection of Occluder Size for Left Atrial Appendage Occlusion: A Meta-Analysis

The value of cardiac computed tomography in assessing device endothelialization after left atrial appendage closure

Influence of Left Atrial Appendage Occlusion on Left Atrial Structures and Function Evaluated with Transthoracic Echocardiography

Assessment of mitral annulus and mitral leaflet in nonvalvular atrial fibrillation patients with various degrees of mitral regurgitation: Real time 3D transesophageal echocardiography

Reference Value of Perimeter‐derived Diameter Assessed by Three‐dimensional Transesophageal Echocardiography in Left Atrial Appendage Occluder Size Selection

Comparison of left atrial appendage measurements between conventional transesophageal echocardiography and "Virtual TEE" reconstructed from computed tomography for pre-procedural planning of device closure

Assessment of mitral valve geometry in nonvalvular atrial fibrillation patients with or without ventricular dysfunction: insights from high volume rate three-dimensional transesophageal echocardiography

A multi-center clinical study of a novel disc-like left atrial appendage closure system: the periprocedural and mid-term outcomes

Impacts of Left Atrial Appendage Treatments on Mitral Valve Diseases during Surgical Ablations

Role of Real Time-Three Dimensional Transesophageal Echocardiography in Left Atrial Appendage Closure with LACBES® Devices.

Real-time three-dimensional transesophageal echocardiography in evaluating on morphology and mechanical function of left atrial appendage in patients with non-valvular atrial fibrillation